# 3D Bio Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/3d-bio-therapeutics

- Industry: Biotechnology
- Headquarters: Long Island City, US
- Latest round: Seed (Apr 10, 2019)
- Investors on record: 1

## About

3D Bio Therapeutics specializes in innovative biotherapeutics, focusing on regenerative medicine and tissue engineering solutions, aiming to transform patient care through cutting-edge therapies.3D Bio Therapeutics is dedicated to developing advanced regenerative therapies. Founded in 2014 and based in Brooklyn, US, the company has completed one deal, with its most recent funding round occurring on April 10, 2019. The founder, who has a history of entrepreneurial ventures, established this firm to address critical needs in the healthcare sector.The company offers a suite of innovative biotherapeutics focused on regenerative medicine and tissue engineering solutions. Their core products provide advanced therapies for a range of medical conditions, designed to enhance patient recovery and improve health outcomes. Targeting healthcare providers, hospitals, and research institutions globally, including markets in North America and Europe, 3D Bio Therapeutics aims to address various medical needs through its specialized offerings.The company generates revenue through the commercialization of its biotherapeutic products. This includes structured agreements with healthcare providers and institutions, typically operating under a contract basis that allows for flexible pricing. Revenue is primarily derived from the sale of its innovative therapies, ensuring continuous investment in research and development to support product enhancements and expansions.3D Bio Therapeutics plans to launch new regenerative therapy products by the end of 2023, targeting specific medical applications that are currently underserved. Additionally, the company aims to expand its presence into European and Asian markets by 2024. The recent funding round, secured in April 2019 from Blue Collective, will be utilized to support these initiatives, enhancing product development and market entry strategies.

## Funding rounds

- Seed, Apr 10, 2019 — Blue Collective

## Investors

- Blue Collective (https://capitalatlas.ai/funds/blue-collective) — Seed